FDA is requesting OMB approval for the
reporting requirements contained in the FDA collection of
information "Environmental Impact Considerations." The National
Environmental Policy Act (NEPA) (42 U.S.C. 4321-4347) states
national environmental objectives and imposes upon each Federal
agency the duty to consider the environmental effects of its
actions that will significantly affect the quality of the human
environment. The FDA NEPA regulations are contained in 21 CFR part
25. All applications or petitions requesting Agency action require
the submission of a claim for a categorical exclusion or an
environmental assessment (EA). This collection of information is
used by FDA to assess the environmental impact of Agency actions
and to ensure that the public is informed of environmental
analyses. Firms wishing to manufacture and market substances
regulated under statutes for which FDA is responsible must, in most
instances, submit applications requesting approval. Environmental
information must be included in such applications for the purpose
of determining whether the proposed action may have a significant
impact on the environment. Where significant adverse effects cannot
be avoided, the Agency uses the submitted information as the basis
for preparing and circulating to the public an EIS, made available
through a FEDERAL REGISTER notice also filed for comment at the
Environmental Protection Agency (EPA). If the Agency finds that no
significant environmental effects are expected, the Agency prepares
a FONSI. The respondents to this collection are primarily from the
private sector businesses.
US Code:
42 USC 4321-4347 Name of Law: National Environmental Policy
Act
The revised projected burden is
expected to decrease by 5,387 hours (193,817 currently approved
burden hours minus 188,430 projected burden hours.) The revised
estimates are the result of updated data from each of FDA's
Centers, and are based on the updated Center information summarized
below for claims for categorical exclusions and EAs submitted
during 2011 and on the addition of burden for environmental
assessments for tobacco products added to this collection. A
summary of the changes is discussed in the supporting statement in
detail.
$1,160,000
No
No
No
No
No
Uncollected
Daniel Gitteson 3017965156
daniel.gitteson@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.